Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
Sermsiri Sangroongruangsri,1 Usa Chaikledkaew,1,2 Prut Hanusaha,3 Tanapat Ratanapakorn,4 Paisan Ruamviboonsuk5 1Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand; 2Mahidol University Health Technology Assessment (MUHTA) Gr...
Enregistré dans:
Auteurs principaux: | Sangroongruangsri S (Auteur), Chaikledkaew U (Auteur), Hanusaha P (Auteur), Ratanapakorn T (Auteur), Ruamviboonsuk P (Auteur) |
---|---|
Format: | Livre |
Publié: |
Dove Medical Press,
2021-11-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy
par: Peng Y, et autres
Publié: (2018) -
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
par: Hsin-Yu Weng, et autres
Publié: (2019) -
Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
par: Yinchen Shen, et autres
Publié: (2022) -
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy
par: Misa Kimura, et autres
Publié: (2024) -
Avoiding errors in the diagnosis of polypoidal choroidal vasculopathy in patients with age-related macular degeneration (Part 1)
par: Lutsenko N. S., et autres
Publié: (2021)